Parkinsonianlike signs and risk of incident alzheimer disease in older persons

Archives of Neurology

Volumn 60, Issue 4, 2003, Pages 539-544

  Wilson, Robert S ^a,b   Schneider, Julie A ^a,b   Bienias, Julia L ^a,b   Evans, Denis A ^a,b   Bennett, David A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GAIT DISORDER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; PRIORITY JOURNAL; RIGIDITY; RISK ASSESSMENT;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PARKINSON DISEASE; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 0037387048     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.4.539     Document Type: Article

References (39)

1. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996;334:71-76.
2. Critchley M. The neurology of old age. Lancet. 1931;1:1221-1230.
3. Kaye JA, Oken BS, Howieson DB, Howieson J, Holm LA, Dennison K. Neurologic evaluation of the optimally healthy oldest old. Arch Neurol. 1994;51:1205-1211.
4. Richards M, Stern Y, Marder K, Cote L, Mayeux R. Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. Ann Neurol. 1993;33:267-274.
5. Wilson RS, Schneider JA, Beckett LA, Evans DA, Bennett DA. Progression of gait disorder and rigidity and risk of death in older persons. Neurology. 2002;58:1815-1819.
6. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology. 1993;43:2184-2188.
7. Bennett DA, Shannon KM, Beckett LA, Wilson RS. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 1999;54A:M191-M196.
8. Folstein M, Folstein S, McHugh P. Mini-mental state: a practical method for grading the mental state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
9. Wilson RS, Mendes de Leon CF, Barnes LL, et al. Participation in cognitively stimulating activities and risk of incident Alzheimer's disease. JAMA. 2002;287:742-748.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
11. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology. 1997;49:1580-1586.
12. Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Goldstein M, Calne D, eds. Recent Developments in Parkinson's Disease. Vol 12. Florham Park, NJ: MacMillan Healthcare Information; 1987:153-163.
13. Wilson RS, Bennett DA, Gilley DW, Beckett LA, Schneider JA, Evans DA. Progression of parkinsonian signs in Alzheimer's disease. Neurology. 2000;54:1284-1289.
14. Wilson RS, Bennett DA, Gilley DW, Beckett LA, Schneider JA, Evans DA. Progression of parkinsonism and loss of cognitive function in Alzheimer's disease. Arch Neurol. 2000;57:855-860.
15. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part V: a normative study of the neuropsychological battery. Neurology. 1994;44:609-614.
16. Albert MS, Smith L, Scherr P, Taylor J, Evans DA, Funkenstein H. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci. 1991;57:167-178.
17. Weschler D. Wechsler Memory Scale-Revised Manual. San Antonio, Tex: Psychological Corp; 1987.
18. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia, Pa: Lea & Febiger; 1983.
19. Ekstrom RB, French JW, Harman HH, Kermen D. Manual for Kit of Factor-Referenced Cognitive Tests. Princeton, NJ: Educational Testing Service; 1976.
20. Nelson HE. National Adult Reading Test (NART) Test Manual. Windsor, England: NFER-NELSON Publishing Co; 1982.
21. Cooper JA, Sager HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain. 1991;114:2095-2122.
22. Craik FIM. A functional account of age differences in memory. In: Klix E, Hagendorf H, eds. Human Memory and Cognitive Capabilities: Mechanisms and Performances. Amsterdam, the Netherlands: Elsevier Science Publishers; 1986:409-422.
23. Smith A. Symbol Digit Modalities Test Manual - Revised. Los Angeles, Calif: Western Psychological Services; 1982.
24. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to Neuropsychological Assessment. 2nd ed. New York, NY: Oxford University Press; 1992.
25. Raven JC, Court JH, Raven J. Manual for Raven's Progressive Matrices and Vocabulary Scales. Oxford, England: Oxford University Press; 1992.
26. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging. 2002;17:179-193.
27. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res. 1990;31:545-548.
28. Laird N, Ware J. Random-effects models for longitudinal data. Biometrics. 1982;38:963-974.
29. Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA. Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol Aging. 2000;15:18-28.
30. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;74:187-220.
31. Becker R, Chambers J, Wilks A. The New S Language. New York, NY: Chapman & Hall; 1988.
32. Venables W, Ripley B. Modern Applied Statistics With S-Plus. New York, NY: Springer-Verlag; 1994.
33. SAS Institute Inc. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute Inc; 2000.
34. Richards M, Bell K, Dooneief G, et al. Patterns of neuropsychological performance in Alzheimer's disease patients with and without extrapyramidal signs. Neurology. 1993;43:1708-1711.
35. Richards M, McLaughlin D, Levy R. The relationship between extrapyramidal signs and cognitive function in patients with moderate to severe Alzheimer's disease. Int J Geriatr Psychiatry, 1995;10:395-399.
36. Liu Y, Stern Y, Chun M, Jacobs D, Yau P, Goldman J. Pathological correlates of extrapyramidal signs in Alzheimer's disease. Ann Neurol. 1997;41:368-374.
37. Ditter S, Mirra S. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease. Neurology. 1987;37:754-760.
38. Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part IX: a prospective clinic neuropathologic study of Parkinson's features in Alzheimer's disease. Neurology. 1995;45:1991-1995.
39. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999;56:98-102.